Ionis Pharmaceuticals, Inc. | TalkMarkets

Latest Posts

Biotech (Top 30 Weights) 2019 Earnings Estimates Up 8.58% In Last 2 Months

Article By: T.J. Hayes

Monday, September 9, 2019 7:36 PM EDT

The cumulative earnings power of these 30 stocks was revised UP by 8.58% in the past 60 days.

In this article: ALNY, ALXN, BMRN, CBPO, ILMN, INCY, JAZZ, REGN, SGEN, AMGN, BIIB, CELG, EXEL, GILD, HZNP, MYL, NBIX, TECH, VRTX, AMRN, SAGE, GWPH, SRPT, BLUE, NVCR, IONS, BGNE, PRAH, SYNH, IBB

Read

The Week Ahead In Biotech: Conferences, PDUFA Dates, Clinical Trial Readouts And IPOs

Article By: Benzinga

Saturday, April 27, 2019 6:05 PM EDT

Biotech stocks staged a recovery this week after being in the red in the previous two weeks.

In this article: BTX, BOLD, REGN, BIIB, GWPH, ALDX, HRTX, IONS, ADAP, NBRV, BHVN, NVS, SNY, RHHBY, ABBV

Read

Akcea, Ionis Slide After FDA Document Highlights Volanesorsen 'Safety Concerns'

Article By: The Fly

Tuesday, May 8, 2018 12:51 PM EDT

Shares of Ionis Pharmaceuticals and its majority-owned spinout Akcea Therapeutics are sliding after the Food and Drug Administration posted its briefing document ahead of Thursday's meeting to discuss the latter's volanesorsen.

In this article: IONS Also: AKCA, ALNY

Read

Akcea Falls After FDA Panel Discusses 'Safety Concerns' Of Volanesorsen

Article By: The Fly

Tuesday, May 8, 2018 9:37 AM EDT

Akcea Therapeutics and its controlling holder Ionis Pharmaceuticals are moving lower after an FDA panel posted its briefing document ahead of Thursday's meeting to discuss Akcea's volanesorsen.

In this article: AKCA, IONS

Read